Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Brenda Hutcheson"'
Autor:
Brenda Hutcheson, Ines Brechoire, Michal L. Schwartzman, Gregory Joseph, Petra Rocic, Spencer D. Proctor, Catherine D'Addario, John R. Falck, Amanda Soler
Publikováno v:
The FASEB Journal. 33
Autor:
Kyle McEvoy, Petra Rocic, Gregory Joseph, Catherine D'Addario, Brenda Hutcheson, Rashmi Jadhav
Publikováno v:
The FASEB Journal. 32
Autor:
Ian Hunter, Petra Rocic, John R. Falck, Brenda Hutcheson, Michal L. Schwartzman, Chastity Bradford, Spencer D. Proctor, Sachindra R. Joshi, Katherine H. Gotlinger, Jenny Yang, Frank Zhang, Kyle McEvoy, Amanda Soler
Publikováno v:
The FASEB Journal. 32
Autor:
Gregory Joseph, Petra Rocic, Ian Hunter, Rebecca Hutcheson, Michal L. Schwartzman, Rachana Maniyar, John R. Falck, Frank Zhang, Brenda Hutcheson, Katherine H. Gotlinger, Spencer D. Proctor, Chastity Bradford, Sachindra R. Joshi, Jenny Yang, Amanda Soler, Sachin A. Gupte
Publikováno v:
Journal of molecular and cellular cardiology. 117
Arterial stiffness plays a causal role in development of systolic hypertension. 20-hydroxyeicosatetraeonic acid (20-HETE), a cytochrome P450 (CYP450)-derived arachidonic acid metabolite, is known to be elevated in resistance arteries in hypertensive
Autor:
Petra Rocic, Jennifer Chaplin, Robert A. Barrington, Erika Smith, Brenda Hutcheson, Russell Terry, Rebecca Hutcheson, Spencer D. Proctor, Rashmi Jadhav
Publikováno v:
American Journal of Physiology-Heart and Circulatory Physiology. 308:H1323-H1335
Coronary collateral growth (CCG) is impaired in metabolic syndrome. microRNA-21 (miR-21) is a proproliferative and antiapoptotic miR, which we showed to be elevated in metabolic syndrome. Here we investigate whether impaired CCG in metabolic syndrome
Autor:
Amanda A Soler, Brenda Hutcheson, Jenny Yang, Chastity Bradford, Frank F Zhang, Katie H Gotlinger, Michal L Schwartzman, Petra Rocic
Publikováno v:
Hypertension. 70
Increased intra-abdominal (visceral) adipose tissue is a key feature of the metabolic syndrome affecting over 30% of the U.S. population. Expansion of visceral adipose tissue is linked to the development of hypertension and is a risk factor for cardi
Autor:
Amanda A Soler, Ian Hunter, Gregory Joseph, Rebecca Hutcheson, Brenda Hutcheson, Jenny Yang, Frank F Zhang, Sachindra R Joshi, Chastity Bradford, Katherine H Gotlinger, Rachana Maniyar, John R Falck, Spencer Proctor, Michal L Schwartzman, Sachin A Gupte, Petra Rocic
Publikováno v:
Hypertension. 70
Large artery stiffness is a causal factor in development of systolic hypertension. 20-hydroxyeicosatetraeonic acid (20-HETE), a cytochrome CYP450-derived arachidonic acid metabolite, is known to be elevated in resistance arteries in hypertensive anim
Autor:
Brenda Hutcheson, Petra Rocic, Spencer D. Proctor, Rebecca Hutcheson, Michal L. Schwartzman, Houli Jiang, Amanda Soler, John R. Falck, Chastity Bradford, Ian Hunter, Gregory Joseph, Katherine H. Gotlinger
Coronary collateral growth (CCG) is impaired in metabolic syndrome (MetS). microRNA-145 (miR-145-Adv) delivery to our rat model of MetS (JCR) completely restored and neutrophil depletion significantly improved CCG. We determined whether low endogenou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a235b8b806bf57c217d3f3b11fbf389d
https://europepmc.org/articles/PMC5402017/
https://europepmc.org/articles/PMC5402017/
Autor:
Rebecca Hutcheson, Katherine H. Gotlinger, Gregory Joseph, Spencer D. Proctor, Chastity Bradford, John R. Falck, Amanda Soler, Ian Hunter, Brenda Hutcheson, Petra Rocic, Michal L. Schwartzman
Publikováno v:
Hypertension. 68
Transient, repetitive myocardial ischemia (RI)-induced coronary collateral growth (CCG) is impaired in metabolic syndrome patients and animal models. Endothelial cell (EC) dysfunction and chronic inflammation are hallmarks of metabolic syndrome. We s
Autor:
Petra Rocic, Katie Gotlinger, Jenny Yang, Amanda Soler, Frank Zhang, Michal L. Schwartzman, Brenda Hutcheson, Chastity Bradford
Publikováno v:
Hypertension. 68
Central (visceral) obesity is a key feature of the metabolic syndrome and an independent predictor of cardiovascular disease. Reux en Y gastric bypass (RnY) has been shown to offer protection against cardiovascular disease, but residual risk remains.